Since GCs bind to the glucocorticoid receptor, a transcriptional activator and repressor with multiple well-known targets, we cannot rule out the possibility that the observed anti-tumor effects are due solely to up-regulation of Na,K-β1. This evidence concerns the gene NR3C1 and neoplasm.